Veru (VERU) News Today $0.72 -0.04 (-5.26%) (As of 12/29/2023 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVeru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugsfinance.yahoo.com - December 19 at 10:15 AMThe Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 29%finance.yahoo.com - December 18 at 8:23 AMVERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firmtmcnet.com - December 14 at 10:40 PMVeru stock falls after it prices its public offering at $0.72 per sharemsn.com - December 14 at 12:40 PMMets address signing free agent who endured ‘bad luck’nj.com - December 5 at 2:30 PMLuton Town back Bedfordshire Police's knife crime campaignmsn.com - November 23 at 7:56 AMVeru Inc. (VERU) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - November 11 at 7:57 AMThe past year for Veru (NASDAQ:VERU) investors has not been profitablefinance.yahoo.com - November 10 at 10:51 AMVERU INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Veru Inc. - VERUbenzinga.com - October 16 at 3:56 PMTandridge restaurant given new food hygiene ratingmsn.com - October 13 at 7:52 AMVeru Inc. (VERU)ca.finance.yahoo.com - October 6 at 12:54 AMPromising Drug Development Pipeline Bolsters Buy Rating for Veru: Enobosarm’s Potential and Upcoming Trials in Focusmarkets.businessinsider.com - October 5 at 9:53 AMVeru to conduct Phase2b study with enobosarm, GLP-1 weight-loss drugsmsn.com - October 4 at 1:41 PMVeru Reports Muscle Data from 5 Clinical Studies of Enobosarm that Support the Advancement of Enobosarm in Combination with Weight-Loss GLP-1 Drugs, Ozempic®, Wegovy®, or Mounjaro®, to Optimize Weight Loss by Preventing Muscle Wasting and Further Increasing Fat Loss in a Phase 2b Obesity Clinical Studyfinance.yahoo.com - October 4 at 8:41 AMPromising Drug Developments Bolster Veru’s Buy Rating: An Analysis of Sabizabulin and Enobosarm Trialsmarkets.businessinsider.com - September 27 at 7:42 AMVeru Reaches Agreement with FDA on New Phase 3 Clinical Trial for Sabizabulin for Broader Indication: Hospitalized Adult Patients with Any Type of Viral Acute Respiratory Distress Syndrome (ARDS)finance.yahoo.com - September 26 at 10:28 AMVeru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023finance.yahoo.com - September 20 at 9:24 AMVeru Reports Clinical Data from the Discontinued ARTEST Study of Enobosarm, Novel Selective Androgen Receptor Targeting Agonist, in AR+ ER+ HER2- Metastatic Breast Cancerfinance.yahoo.com - September 11 at 6:53 PMVeru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023finance.yahoo.com - August 30 at 8:36 AMVeru: Stocks are being driven down by high valuations despite strong earningsmsn.com - August 28 at 12:43 PMVeru Inc. (NASDAQ:VERU) Analysts Just Trimmed Their Revenue Forecasts By 25%finance.yahoo.com - August 16 at 7:18 AMH.C. Wainwright Reaffirms Their Buy Rating on Veru (VERU)markets.businessinsider.com - August 14 at 2:10 PMWhat You Can Learn From Veru Inc.'s (NASDAQ:VERU) P/Sfinance.yahoo.com - August 11 at 5:09 PMVeru GAAP EPS of $0.07 beats by $0.27, revenue of $3.34M misses by $6.88Mmsn.com - August 10 at 9:31 AMVeru Reports Fiscal 2023 Third Quarter Financial Resultsfinance.yahoo.com - August 10 at 9:31 AMVeru to Report Fiscal 2023 Third Quarter Financial Results on August 10, 2023finance.yahoo.com - August 3 at 12:25 PMBaby Movie Review: An odious, operatic tragedy of errorsmsn.com - August 1 at 2:46 PMStay Away From Veru Until 2024msn.com - July 20 at 6:09 PMVeru: Markets don't appreciate the rapid change in liquidity conditionscnbc.com - July 10 at 7:41 AMVeru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grantsfinance.yahoo.com - June 21 at 1:29 PM98,255 Shares in Veru Inc. (NASDAQ:VERU) Bought by ETF Managers Group LLCmarketbeat.com - June 19 at 5:24 AMJefferies Upgrades Veru (VERU)msn.com - June 7 at 9:22 PMJefferies upgrades Veru to hold, cites upcoming breast cancer study datamsn.com - June 7 at 4:22 PM6 Analysts Have This to Say About Verumarkets.businessinsider.com - June 7 at 4:22 PMWhat 6 Analyst Ratings Have To Say About Verumarkets.businessinsider.com - June 7 at 10:38 AMVeru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Boardfinance.yahoo.com - June 1 at 9:53 AMVeru to Present at the Jefferies Healthcare Conferencefinance.yahoo.com - May 24 at 8:58 AMHC Wainwright & Co. Maintains Veru (VERU) Buy Recommendationmsn.com - May 15 at 4:58 PMH.C. Wainwright Sticks to Its Buy Rating for Veru (VERU)markets.businessinsider.com - May 15 at 8:36 AMVeru Inc.: Veru Reports Fiscal 2023 Second Quarter Financial Resultsfinanznachrichten.de - May 12 at 8:49 PMVeru Q2: Revenue Halves, Prioritizes Clinical Programs, Wider Loss & Moremsn.com - May 12 at 10:49 AMVeru Inc. (VERU) Reports Q2 Loss, Tops Revenue Estimatesfinance.yahoo.com - May 11 at 1:35 PMVeru: Q2 Earnings Insightsmsn.com - May 11 at 8:34 AMVERU Stock Earnings: Veru Misses EPS, Beats Revenue Estimatesmarkets.businessinsider.com - May 11 at 8:34 AMVeru Reports Fiscal 2023 Second Quarter Financial Resultsfinance.yahoo.com - May 11 at 8:34 AMAnalyst Ratings for Verumarkets.businessinsider.com - May 10 at 3:55 PMA Preview Of Veru's Earningsmsn.com - May 10 at 3:55 PMVeru Q2 2023 Earnings Previewmsn.com - May 10 at 3:55 PMIs a Surprise Coming for Veru (VERU) This Earnings Season?finance.yahoo.com - May 9 at 3:10 PMVeru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDSfinance.yahoo.com - May 4 at 1:26 PM Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address VERU Media Mentions By Week VERU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERU News Sentiment▼1.890.84▲Average Medical News Sentiment VERU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERU Articles This Week▼11▲VERU Articles Average Week Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACET News EGRX News APLM News ADAG News IFRX News CLNN News CLSD News SCYX News BCTX News ACRS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:VERU) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.